{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:26:52Z","timestamp":1758274012453,"version":"3.27.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,14]]},"DOI":"10.7759\/cureus.37596","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T04:13:47Z","timestamp":1681532027000},"source":"Crossref","is-referenced-by-count":4,"title":["A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India"],"prefix":"10.7759","author":[{"given":"Shaik","family":"Ashifha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jami","family":"Vijayashree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirankanth","family":"Vudayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilipchandra","family":"Chintada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavani","family":"P","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi","family":"G","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17072209","article-title":"Physicians' understanding and practices of pharmacovigilance: qualitative experience from a lower middle-income country","volume":"17","author":"Hussain R","year":"2020","unstructured":"Hussain R, Hassali MA, Ur Rehman A, Muneswarao J, Hashmi F. Physicians' understanding and practices of pharmacovigilance: qualitative experience from a lower middle-income country. Int J Environ Res Public Health. 2020, 17:2209. 10.3390\/ijerph17072209","journal-title":"Int J Environ Res Public Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-5-481","article-title":"Adverse drug reactions","volume":"16","author":"Coleman JJ","year":"2016","unstructured":"Coleman JJ, Pontefract SK. Adverse drug reactions. Clin Med (Lond). 2016, 16:481-485. 10.7861\/clinmedicine.16-5-481","journal-title":"Clin Med (Lond)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.19723\/j.issn.1671-167X.2019.05.032","article-title":"Drug-induced toxic epidermal necrolysis with secondary Aspergillus fumigatus infection: a case report","volume":"51","author":"Zhang S","year":"2019","unstructured":"Zhang S, Liu XY, Zhang JZ, Cai L, Zhou C. Drug-induced toxic epidermal necrolysis with secondary Aspergillus fumigatus infection: a case report. Beijing Da Xue Xue Bao Yi Xue Ban. 2019, 51:977-980. 10.19723\/j.issn.1671-167X.2019.05.032","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_261_17","article-title":"A study of cutaneous adverse drug reactions and their association with autoimmune diseases at a tertiary centre in South-West Rajasthan, India","volume":"66","author":"Rana S","year":"2021","unstructured":"Rana S, Gupta K, Agarwal N, Ahamed AN. A study of cutaneous adverse drug reactions and their association with autoimmune diseases at a tertiary centre in South-West Rajasthan, India. Indian J Dermatol. 2021, 66:445. 10.4103\/ijd.IJD_261_17","journal-title":"Indian J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-015-0540-2","article-title":"Adverse cutaneous drug eruptions: current understanding","volume":"38","author":"Hoetzenecker W","year":"2016","unstructured":"Hoetzenecker W, N\u00e4geli M, Mehra ET, et al.. Adverse cutaneous drug eruptions: current understanding. Semin Immunopathol. 2016, 38:75-86. 10.1007\/s00281-015-0540-2","journal-title":"Semin Immunopathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13430","article-title":"Severe cutaneous adverse drug reactions","volume":"43","author":"Chung WH","year":"2016","unstructured":"Chung WH, Wang CW, Dao RL. Severe cutaneous adverse drug reactions. J Dermatol. 2016, 43:758-766. 10.1111\/1346-8138.13430","journal-title":"J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/164_2021_490","article-title":"Drug allergy and cutaneous adverse reactions","volume":"268","author":"Mockenhaupt M","year":"2022","unstructured":"Mockenhaupt M. Drug allergy and cutaneous adverse reactions. Handb Exp Pharmacol. 2022, 268:195-212. 10.1007\/164_2021_490","journal-title":"Handb Exp Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/cod.14063","article-title":"Skin tests in the work-up of cutaneous adverse drug reactions: a review and update","volume":"86","author":"Barbaud A","year":"2022","unstructured":"Barbaud A, Castagna J, Soria A. Skin tests in the work-up of cutaneous adverse drug reactions: a review and update. Contact Dermatitis. 2022, 86:344-356. 10.1111\/cod.14063","journal-title":"Contact Dermatitis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2022.02.002","article-title":"Postmarket assessment for drugs and biologics used in dermatology and cutaneous adverse drug reactions","volume":"40","author":"Reyes M","year":"2022","unstructured":"Reyes M, Kortepeter C, Mu\u00f1oz M. Postmarket assessment for drugs and biologics used in dermatology and cutaneous adverse drug reactions. Dermatol Clin. 2022, 40:265-277. 10.1016\/j.det.2022.02.002","journal-title":"Dermatol Clin"},{"key":"ref10","article-title":"Adverse cutaneous drug reactions: clinical pattern and causative agents in a tertiary care center in South India","volume":"70","author":"Pudukadan D","year":"2004","unstructured":"Pudukadan D, Thappa DM. Adverse cutaneous drug reactions: clinical pattern and causative agents in a tertiary care center in South India. Indian J Dermatol Venereol Leprol. 2004, 70:20-24.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.42883","article-title":"Clinical study of cutaneous drug eruptions in 200 patients","volume":"74","author":"Patel RM","year":"2008","unstructured":"Patel RM, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol. 2008, 74:430. 10.4103\/0378-6323.42883","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.4103\/CDR.CDR_109_20","article-title":"A study of cutaneous adverse drug reactions in a tertiary care center in South India","volume":"5","author":"Rajendran L","year":"2021","unstructured":"Rajendran L, Thyvalappil A, Sridharan R, Ajayakumar S, Deep S, Divakaran B. A study of cutaneous adverse drug reactions in a tertiary care center in South India. Clin Dermatol Rev. 2021, 5:173-177.","journal-title":"Clin Dermatol Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_81_18","article-title":"A study of cutaneous adverse drug reactions in a tertiary care center in Punjab","volume":"9","author":"Jha N","year":"2018","unstructured":"Jha N, Alexander E, Kanish B, Badyal DK. A study of cutaneous adverse drug reactions in a tertiary care center in Punjab. Indian Dermatol Online J. 2018, 9:299-303. 10.4103\/idoj.IDOJ_81_18","journal-title":"Indian Dermatol Online J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.156384","article-title":"A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India","volume":"6","author":"Sharma R","year":"2015","unstructured":"Sharma R, Dogra D, Dogra N. A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India. Indian Dermatol Online J. 2015, 6:168-171. 10.4103\/2229-5178.156384","journal-title":"Indian Dermatol Online J"},{"key":"ref15","article-title":"Epidemiological study of cutaneous adverse drug reactions in Oman","volume":"23","author":"Al-Raaie F","year":"2008","unstructured":"Al-Raaie F, Banodkar DD. Epidemiological study of cutaneous adverse drug reactions in Oman. Oman Med J. 2008, 23:21-27.","journal-title":"Oman Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.103304","article-title":"Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India","volume":"44","author":"Saha A","year":"2012","unstructured":"Saha A, Das NK, Hazra A, Gharami RC, Chowdhury SN, Datta PK. Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India. Indian J Pharmacol. 2012, 44:792-797. 10.4103\/0253-7613.103304","journal-title":"Indian J Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.28212","article-title":"Adverse cutaneous drug reactions: a one year survey at a dermatology outpatient clinic of a tertiary care hospital","volume":"38","author":"Chatterjee S","year":"2006","unstructured":"Chatterjee S, Ghosh AP, Barbhuiya J, Dey SK. Adverse cutaneous drug reactions: a one year survey at a dermatology outpatient clinic of a tertiary care hospital. Indian J Pharmacol. 2006, 38:429. 10.4103\/0253-7613.28212","journal-title":"Indian J Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.147834","article-title":"Severe cutaneous adverse drug reactions: a clinicoepidemiological study","volume":"60","author":"Sasidharanpillai S","year":"2015","unstructured":"Sasidharanpillai S, Riyaz N, Khader A, Rajan U, Binitha MP, Sureshan DN. Severe cutaneous adverse drug reactions: a clinicoepidemiological study. Indian J Dermatol. 2015, 60:102. 10.4103\/0019-5154.147834","journal-title":"Indian J Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.102367","article-title":"An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia","volume":"78","author":"Choon SE","year":"2012","unstructured":"Choon SE, Lai NM. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia. Indian J Dermatol Venereol Leprol. 2012, 78:734-739. 10.4103\/0378-6323.102367","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.189662","article-title":"Phenytoin-induced toxic epidermal necrolysis: review and recommendations","volume":"7","author":"Al-Quteimat OM","year":"2016","unstructured":"Al-Quteimat OM. Phenytoin-induced toxic epidermal necrolysis: review and recommendations. J Pharmacol Pharmacother. 2016, 7:127-132. 10.4103\/0976-500X.189662","journal-title":"J Pharmacol Pharmacother"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: Part I. Clinical perspectives","volume":"68","author":"Husain Z","year":"2013","unstructured":"Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part I. Clinical perspectives. J Am Acad Dermatol. 2013, 68:693.e1-693.e14. 10.1016\/j.jaad.2013.01.033","journal-title":"J Am Acad Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18879","article-title":"Cutaneous lichenoid drug eruptions: a narrative review evaluating demographics, clinical features and culprit medications","author":"Maul JT","year":"2023","unstructured":"Maul JT, Guillet C, Oschmann A, et al.. Cutaneous lichenoid drug eruptions: a narrative review evaluating demographics, clinical features and culprit medications. J Eur Acad Dermatol Venereol. 2023, 10.1111\/jdv.18879","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref23","article-title":"Causes and features of erythroderma","volume":"43","author":"Tan GF","year":"2014","unstructured":"Tan GF, Kong YL, Tan AS, Tey HL. Causes and features of erythroderma. Ann Acad Med Singap. 2014, 43:391-394.","journal-title":"Ann Acad Med Singap"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/11701.5419","article-title":"Morphological pattern of cutaneous adverse drug reactions due to antiepileptic drugs in Eastern India","volume":"9","author":"Singh PK","year":"2015","unstructured":"Singh PK, Kumar MK, Kumar D, Kumar P. Morphological pattern of cutaneous adverse drug reactions due to antiepileptic drugs in Eastern India. J Clin Diagn Res. 2015, 9:WC01-WC03. 10.7860\/JCDR\/2015\/11701.5419","journal-title":"J Clin Diagn Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/144515-a-study-of-cutaneous-adverse-drug-reactions-at-a-tertiary-care-center-in-andhra-pradesh-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T09:39:06Z","timestamp":1729244346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/144515-a-study-of-cutaneous-adverse-drug-reactions-at-a-tertiary-care-center-in-andhra-pradesh-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.37596","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}